UBS Group AG - ALLIQUA BIOMEDICAL INC ownership

ALLIQUA BIOMEDICAL INC's ticker is ALQA and the CUSIP is 019621309. A total of 19 filers reported holding ALLIQUA BIOMEDICAL INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ALLIQUA BIOMEDICAL INC
ValueSharesWeighting
Q1 2019$13,000
+44.4%
4,564
-6.5%
0.00%
Q4 2018$9,0000.0%4,880
+26.4%
0.00%
Q3 2018$9,000
-10.0%
3,862
-19.5%
0.00%
Q2 2018$10,000
-33.3%
4,798
-40.4%
0.00%
Q4 2017$15,0008,0530.00%
Other shareholders
ALLIQUA BIOMEDICAL INC shareholders Q1 2019
NameSharesValueWeighting ↓
Tekla Capital Management LLC 148,500$278,0000.01%
Perceptive Advisors 114,730$214,0000.01%
Jaffetilchin Investment Partners, LLC 15,502$29,0000.01%
Virtu Financial LLC 25,373$48,0000.00%
Omnia Family Wealth, LLC 1,689$3,0000.00%
JANE STREET GROUP, LLC 12,062$23,0000.00%
UBS Group AG 4,880$9,0000.00%
BANK OF AMERICA CORP /DE/ 5$00.00%
WELLS FARGO & COMPANY/MN 100$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ALLIQUA BIOMEDICAL INC shareholders